Developer docs
API playgroundTry for free, no card

Search company profiles

CRIDCam

Full company profile

uuid0047nuz

Namestring
CRIDCam
Legal namestring
Centre for Research in Infectious Diseases
Websiteurl
crid-cam.com
Company typeenum
Private
Founded yearint
2017
Descriptiontext

CRID (Centre for Research in Infectious Diseases) is a not-for-profit research institution founded in 2017 and headquartered in Yaoundé, Cameroon. It conducts high-quality, internationally recognized research on major vector-borne infectious diseases in Africa, including malaria, sleeping sickness, yellow fever, and emerging threats such as Zika and dengue. The centre is led by Executive Director Professor Charles Wondji and serves national malaria control programmes, African ministries of health, academic and research institutions, and international health organizations including WHO, PMI, and the Bill and Melinda Gates Foundation.

The organization operates an integrated technical platform comprising three core facilities: a Molecular Biology Laboratory for genetic and genomic studies of vectors and pathogens (gene amplification, cloning, Sanger sequencing, genotyping); a Biosafety Level 2 Insectary for rearing mosquitoes and conducting insecticide testing; and an Experimental Field Station in Mibellon, Adamawa Region, for small-scale field trials on insecticide resistance and bed nets. It also offers Sanger sequencing services to external researchers and operates the African Centre for Vector Genomics (AVecGen), a Gates Foundation-funded training programme delivering specialized courses in bioinformatics, R programming, molecular entomology, and population genomics to African scientists.

CRID's revenue is generated almost exclusively through research grants and donor funding from international bodies including the Bill and Melinda Gates Foundation (notably a $3.7M grant in October 2020), Wellcome Trust, UKRI/Global Challenges Research Fund, the EU's IMPACTING programme, PMI via Abt Associates under the Vectorlink project, Unitaid, the Science for Africa Foundation, and the Medical Research Foundation (UK). Go-to-market is event- and partnership-driven, relying on scientific conference participation, training-program recruitment, publications, and direct collaborations with national malaria control programmes and international research consortia. CRID has 12 employees and serves as the designated analytical laboratory for all PMI/Vectorlink entomological samples collected in Cameroon, giving it an unusually concentrated role in national vector surveillance.

Short descriptiontext

CRID is a Cameroonian not-for-profit research institution founded in 2017 that conducts internationally recognized research on vector-borne infectious diseases (malaria, sleeping sickness, Zika, dengue), serving national malaria control programs, African ministries of health, academic researchers, and global health funders.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersYaoundé, Cameroon
HQ citystring
Yaoundé
HQ countrystring
Cameroon
HQ regionstring
Africa
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
infectious disease research, vector genomics surveillance, malaria control research, molecular biology services, public health research
Industry2 codes
1Patient Recruitment, Site Feasibility & Trial Enablement CROs
CodeHLAGAAAIPrimaryYes
2Specialty Therapeutic-Area CROs (e.g., oncology/rare disease)
CodeHLAGAAALPrimaryNo
NAICS code2 codes
  • Scientific Research and Development Services5417
  • Research and Development in Biotechnology (except Nanobiotechnology)541714
SIC code2 codes
  • Services-Commercial Physical & Biological Research8731
  • Services-Medical Laboratories8071
Product category
Infectious Disease Research Services
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Research Grants and Donor Funding
TypeLicensing Royalties
Description

CRID operates as a not-for-profit research institution funded primarily through international research grants and donor funding from organizations such as the Bill and Melinda Gates Foundation, Wellcome Trust, UKRI, EU (IMPACTING programme), and others.

crid-cam.com
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels2 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components4 values
Personnel, Technology or R&D, Operations, Infrastructure
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

CRIDCam (Centre for Research in Infectious Diseases) is a not-for-profit research institution based in Yaoundé, Cameroon, that conducts applied research on vector-borne infectious diseases — principally malaria and its Anopheles vectors — and provides specialized laboratory services, training programmes, and core research facilities. Its service portfolio includes Sanger sequencing, molecular vector surveillance, the AVecGen training curriculum (Bioinformatics and Vector Genomics, and Molecular Vector Surveillance), and access to its Molecular Biology Laboratory, Insectary, and Experimental Field Station for partner institutions and public-health agencies.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • Researchers won first three prizes in all categories at PAMCA 2019 annual conference
+2 more records
Product overview1 text field

CRID (Centre for Research in Infectious Diseases) is a not-for-profit research institution, not a commercial product company. It provides research services and core laboratory facilities rather than software products. The organization's main offerings include: a Molecular Biology Laboratory for genetic/genomic studies, a Biosafety Level 2 Insectary for mosquito rearing, an Experimental Field Station for field trials, and Sanger Sequencing Services. CRID also runs the African Centre for Vector Genomics (AVecGen) training programs in bioinformatics and molecular vector surveillance to build scientific capacity in Africa. The AVecGen training programs are capacity-building initiatives (not commercial products) focused on integrating genomic tools into vector control practices.

Product and service1 record
1Sanger Sequencing Service
Scale indicator3 records

Each record includes

Type, Value, Description, Source

Partnership12 partners
Strategic tierCoreTypeStrategic or Co-development Partner
Description

CRID collaborates with LSTM on the Gates Foundation-funded project for detecting molecular markers of insecticide resistance in malaria vectors. The project involves a Cameroon-based team at CRID and a UK-based team at LSTM, working with partners in Ghana and Uganda. LSTM and CRID also partner on a Wellcome Trust Senior Research Fellowship project led by Dr. Cyrille Ndo.

2Abt Associates (Vectorlink Project)
Strategic tierCoreTypeStrategic or Co-development Partner
Description

CRID has established a partnership with Abt Associates under the Vectorlink project in which CRID has been tasked to analyse all samples from the Vectorlink project in Cameroon to better inform vector control initiatives nation-wide. The partnership provides support from PMI entomologists including Dr. Etienne Fondjo as Chief of Party.

crid-cam.com
Strategic tierCoreTypeStrategic or Co-development Partner
Description

CRID actively participates in PAMCA activities and was a major award winner at the 6th PAMCA Annual Conference in Yaoundé. CRID contributes to PAMCA work streams through knowledge generation and sharing activities focused on analytics and practice of entomological findings.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Prof Rhoel Dinglasan from University of Florida and Director of CDC Southeastern Regional Center of Excellence for Vector Borne Diseases visited CRID to deliver a dengue science talk, exploring potential long-term collaboration on arboviruses and malaria research.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Listed among CRID's institutional partners. WHO recognizes traditional medicine as part of knowledge systems that can contribute to health responses.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Listed among CRID's institutional partners and collaborators.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Listed among CRID's institutional partners and collaborators.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Listed among CRID's institutional partners and collaborators.

9Index Cameroun
Strategic tierMinorTypeStrategic or Co-development Partner
Description

Index Cameroun is listed among CRID's partners and collaborators, supporting the fight against infectious diseases in Cameroon.

crid-cam.com
10IVERM / PAMCA
Strategic tierMinorTypeStrategic or Co-development Partner
Description

IVERM (International Vector Control Research) listed among partners. PAMCA (Pan-African Mosquito Control Association) has phase II grant on 'Strengthening local capacity for malaria surveillance and elimination in Africa' with CRID as implementing partner in Cameroon.

crid-cam.com
Strategic tierMinorTypeStrategic or Co-development Partner
Description

CRID participates in TVCAG (Technical Vector Advisory Group) annual meetings, bringing together expert researchers, stakeholders, research fellows/students and media professionals to assess progress in vector-borne disease control.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Listed among CRID's institutional partners and collaborators.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
1Swiss Tropical and Public Health Institute (Swiss TPH)
TypeBroad incumbent
Description

Major European institute with extensive vector-borne disease, malaria, and capacity-building programmes across Africa, comparable research themes and donor base, but operating at much larger scale and global footprint.

TypeDirect peer
Description

Direct co-investigator on CRID's Gates-funded insecticide resistance project and a Wellcome Trust Senior Research Fellowship partner. Comparable research scope (vector biology, insecticide resistance, capacity building) at much larger scale.

TypeBroad incumbent
Description

French public research organisation with long-standing presence in francophone Africa conducting infectious disease and vector research, overlapping CRID's Cameroon-focused mission and partnership landscape.

TypeDirect peer
Description

Well-established African government-affiliated medical research institute conducting infectious disease and vector biology research with international funder backing. Directly comparable to CRID in mission, funding model, and scope.

TypeDirect peer
Description

Long-standing West African infectious-disease research unit with integrated laboratory and field capabilities, comparable funding base, and similar focus on malaria, vector control and capacity building.

TypeBroad incumbent
Description

Continental public-health body coordinating surveillance and response to infectious diseases across Africa. Sets priorities and channels funding that ultimately flows to research institutions like CRID.

TypeDirect peer
Description

Tanzanian research organisation with comparable vector-borne disease, entomology, and field-trial capabilities, also operating across multiple African geographies and collaborating with similar international funders.

TypeBroad incumbent
Description

Large UK-based global health school with overlapping tropical disease, parasitology, and vector control research, frequently co-funding African institutes. Functions as both collaborator and competitor for the same grant pool.

TypeDirect peer
Description

Yaoundé-based sister institute of the Institut Pasteur network conducting virology, parasitology and vector-borne disease research in the same Cameroonian ecosystem as CRID.

TypeDirect peer
Description

Leading Ghanaian biomedical research institute with strong vector-borne disease and parasitology programmes, also involved in Gates/Wellcome-funded malaria and insecticide resistance work alongside CRID's Ghana partners.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers2 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

CRIDCam

Infectious Disease Research Servicescrid-cam.com

CRID is a Cameroonian not-for-profit research institution founded in 2017 that conducts internationally recognized research on vector-borne infectious diseases (malaria, sleeping sickness, Zika, dengue), serving national malaria control programs, African ministries of health, academic researchers, and global health funders.

What CRIDCam does

CRID (Centre for Research in Infectious Diseases) is a not-for-profit research institution founded in 2017 and headquartered in Yaoundé, Cameroon. It conducts high-quality, internationally recognized research on major vector-borne infectious diseases in Africa, including malaria, sleeping sickness, yellow fever, and emerging threats such as Zika and dengue. The centre is led by Executive Director Professor Charles Wondji and serves national malaria control programmes, African ministries of health, academic and research institutions, and international health organizations including WHO, PMI, and the Bill and Melinda Gates Foundation.

The organization operates an integrated technical platform comprising three core facilities: a Molecular Biology Laboratory for genetic and genomic studies of vectors and pathogens (gene amplification, cloning, Sanger sequencing, genotyping); a Biosafety Level 2 Insectary for rearing mosquitoes and conducting insecticide testing; and an Experimental Field Station in Mibellon, Adamawa Region, for small-scale field trials on insecticide resistance and bed nets. It also offers Sanger sequencing services to external researchers and operates the African Centre for Vector Genomics (AVecGen), a Gates Foundation-funded training programme delivering specialized courses in bioinformatics, R programming, molecular entomology, and population genomics to African scientists.

CRID's revenue is generated almost exclusively through research grants and donor funding from international bodies including the Bill and Melinda Gates Foundation (notably a $3.7M grant in October 2020), Wellcome Trust, UKRI/Global Challenges Research Fund, the EU's IMPACTING programme, PMI via Abt Associates under the Vectorlink project, Unitaid, the Science for Africa Foundation, and the Medical Research Foundation (UK). Go-to-market is event- and partnership-driven, relying on scientific conference participation, training-program recruitment, publications, and direct collaborations with national malaria control programmes and international research consortia. CRID has 12 employees and serves as the designated analytical laboratory for all PMI/Vectorlink entomological samples collected in Cameroon, giving it an unusually concentrated role in national vector surveillance.

CRIDCam firmographics

Firmographics
Name
CRIDCam
Legal name
Centre for Research in Infectious Diseases
Website
https://crid-cam.com
Company type
Private
Founded year
2017
Operating status
Operating
Headcount range
11–50 employees
Short description
CRID is a Cameroonian not-for-profit research institution founded in 2017 that conducts internationally recognized research on vector-borne infectious diseases (malaria, sleeping sickness, Zika, dengue), serving national malaria control programs, African ministries of health, academic researchers, and global health funders.
Ownership category
akta.pro rank

CRIDCam industry classification

Industry
Product category
Infectious Disease Research Services
NAICS
Scientific Research and Development Services (5417), Research and Development in Biotechnology (except Nanobiotechnology) (541714)
SIC
Services-Commercial Physical & Biological Research (8731), Services-Medical Laboratories (8071)
akta.pro primary industry
Patient Recruitment, Site Feasibility & Trial Enablement CROs (HLAGAAAI)
akta.pro secondary industry
Specialty Therapeutic-Area CROs (e.g., oncology/rare disease) (HLAGAAAL)

Keywords

  • Infectious disease research
  • Vector genomics surveillance
  • Malaria control research
  • Molecular biology services
  • Public health research

Where CRIDCam is headquartered

Location

Headquarters

HQ city
Yaoundé
HQ country
Cameroon
HQ region
Africa

Offices2 records

Markets served

CRIDCam business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Technology or R&D, Operations, Infrastructure

Revenue model

  1. Research Grants and Donor Funding: CRID operates as a not-for-profit research institution funded primarily through international research grants and donor funding from organizations such as the Bill and Melinda Gates Foundation, Wellcome Trust, UKRI, EU (IMPACTING programme), and others.

Go-to-market motion1 record

Distribution channels2 records

Marketing channels4 records

CRIDCam product offering

Product offering

Core offering

CRIDCam (Centre for Research in Infectious Diseases) is a not-for-profit research institution based in Yaoundé, Cameroon, that conducts applied research on vector-borne infectious diseases — principally malaria and its Anopheles vectors — and provides specialized laboratory services, training programmes, and core research facilities. Its service portfolio includes Sanger sequencing, molecular vector surveillance, the AVecGen training curriculum (Bioinformatics and Vector Genomics, and Molecular Vector Surveillance), and access to its Molecular Biology Laboratory, Insectary, and Experimental Field Station for partner institutions and public-health agencies.

Product overview

CRID (Centre for Research in Infectious Diseases) is a not-for-profit research institution, not a commercial product company. It provides research services and core laboratory facilities rather than software products. The organization's main offerings include: a Molecular Biology Laboratory for genetic/genomic studies, a Biosafety Level 2 Insectary for mosquito rearing, an Experimental Field Station for field trials, and Sanger Sequencing Services. CRID also runs the African Centre for Vector Genomics (AVecGen) training programs in bioinformatics and molecular vector surveillance to build scientific capacity in Africa. The AVecGen training programs are capacity-building initiatives (not commercial products) focused on integrating genomic tools into vector control practices.

Differentiator

Problem solved

Functional benefit

Products and services

  • Sanger Sequencing Service

Quantifiable outcome

  • Researchers won first three prizes in all categories at PAMCA 2019 annual conference
  • +2 more outcomes

Companies that use CRIDCam

Customer profile

Named customers2 records

Segments3 records

Ideal customer profiles3 records

CRIDCam technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature4 records

CRIDCam partnerships and signals

Strategic signal

Partnerships

Twelve partnerships are on record, tiered core and minor.

  • Liverpool School of Tropical Medicine (LSTM)coreStrategic or Co-development PartnerCRID collaborates with LSTM on the Gates Foundation-funded project for detecting molecular markers of insecticide resistance in malaria vectors. The project involves a Cameroon-based team at CRID and a UK-based team at LSTM, working with partners in Ghana and Uganda. LSTM and CRID also partner on a Wellcome Trust Senior Research Fellowship project led by Dr. Cyrille Ndo.
  • Abt Associates (Vectorlink Project)coreStrategic or Co-development PartnerCRID has established a partnership with Abt Associates under the Vectorlink project in which CRID has been tasked to analyse all samples from the Vectorlink project in Cameroon to better inform vector control initiatives nation-wide. The partnership provides support from PMI entomologists including Dr. Etienne Fondjo as Chief of Party.
  • Pan-African Mosquito Control Association (PAMCA)coreStrategic or Co-development PartnerCRID actively participates in PAMCA activities and was a major award winner at the 6th PAMCA Annual Conference in Yaoundé. CRID contributes to PAMCA work streams through knowledge generation and sharing activities focused on analytics and practice of entomological findings.
  • University of FloridaminorStrategic or Co-development PartnerProf Rhoel Dinglasan from University of Florida and Director of CDC Southeastern Regional Center of Excellence for Vector Borne Diseases visited CRID to deliver a dengue science talk, exploring potential long-term collaboration on arboviruses and malaria research.
  • World Health Organization (WHO)minorStrategic or Co-development PartnerListed among CRID's institutional partners. WHO recognizes traditional medicine as part of knowledge systems that can contribute to health responses.
  • London School of Hygiene & Tropical Medicine (LSHTM)minorStrategic or Co-development PartnerListed among CRID's institutional partners and collaborators.
  • Imperial College LondonminorStrategic or Co-development PartnerListed among CRID's institutional partners and collaborators.
  • University of GlasgowminorStrategic or Co-development PartnerListed among CRID's institutional partners and collaborators.
  • Index CamerounminorStrategic or Co-development PartnerIndex Cameroun is listed among CRID's partners and collaborators, supporting the fight against infectious diseases in Cameroon.
  • IVERM / PAMCAminorStrategic or Co-development PartnerIVERM (International Vector Control Research) listed among partners. PAMCA (Pan-African Mosquito Control Association) has phase II grant on 'Strengthening local capacity for malaria surveillance and elimination in Africa' with CRID as implementing partner in Cameroon.
  • IVERM / TVCAGminorStrategic or Co-development PartnerCRID participates in TVCAG (Technical Vector Advisory Group) annual meetings, bringing together expert researchers, stakeholders, research fellows/students and media professionals to assess progress in vector-borne disease control.
  • WHO/TDR (Special Programme for Research and Training in Tropical Diseases)minorStrategic or Co-development PartnerListed among CRID's institutional partners and collaborators.

Scale indicators3 records

Recent moves6 records

Expansion highlights6 records

CRIDCam competitors and assessment

Company assessment

Broad incumbents

  • Swiss Tropical and Public Health Institute (Swiss TPH): Major European institute with extensive vector-borne disease, malaria, and capacity-building programmes across Africa, comparable research themes and donor base, but operating at much larger scale and global footprint.
  • Institut de Recherche pour le Développement (IRD): French public research organisation with long-standing presence in francophone Africa conducting infectious disease and vector research, overlapping CRID's Cameroon-focused mission and partnership landscape.
  • Africa Centres for Disease Control and Prevention (Africa CDC): Continental public-health body coordinating surveillance and response to infectious diseases across Africa. Sets priorities and channels funding that ultimately flows to research institutions like CRID.
  • London School of Hygiene & Tropical Medicine (LSHTM): Large UK-based global health school with overlapping tropical disease, parasitology, and vector control research, frequently co-funding African institutes. Functions as both collaborator and competitor for the same grant pool.

Direct peers

  • Liverpool School of Tropical Medicine (LSTM): Direct co-investigator on CRID's Gates-funded insecticide resistance project and a Wellcome Trust Senior Research Fellowship partner. Comparable research scope (vector biology, insecticide resistance, capacity building) at much larger scale.
  • Kenya Medical Research Institute (KEMRI): Well-established African government-affiliated medical research institute conducting infectious disease and vector biology research with international funder backing. Directly comparable to CRID in mission, funding model, and scope.
  • MRC Unit The Gambia at LSHTM: Long-standing West African infectious-disease research unit with integrated laboratory and field capabilities, comparable funding base, and similar focus on malaria, vector control and capacity building.
  • Ifakara Health Institute: Tanzanian research organisation with comparable vector-borne disease, entomology, and field-trial capabilities, also operating across multiple African geographies and collaborating with similar international funders.
  • Pasteur Institute of Cameroon: Yaoundé-based sister institute of the Institut Pasteur network conducting virology, parasitology and vector-borne disease research in the same Cameroonian ecosystem as CRID.
  • Noguchi Memorial Institute for Medical Research (NMIMR): Leading Ghanaian biomedical research institute with strong vector-borne disease and parasitology programmes, also involved in Gates/Wellcome-funded malaria and insecticide resistance work alongside CRID's Ghana partners.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

CRIDCam social profiles

Digital presence

CRIDCam financial estimates

Financial estimate

Revenue estimate

Valuation estimate

CRIDCam leadership team

Management profile

Number of profiles

CRIDCam funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

CRIDCam M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about CRIDCam

What does CRIDCam do?

CRIDCam (Centre for Research in Infectious Diseases) is a not-for-profit research institution based in Yaoundé, Cameroon, that conducts applied research on vector-borne infectious diseases — principally malaria and its Anopheles vectors — and provides specialized laboratory services, training programmes, and core research facilities. Its service portfolio includes Sanger sequencing, molecular vector surveillance, the AVecGen training curriculum (Bioinformatics and Vector Genomics, and Molecular Vector Surveillance), and access to its Molecular Biology Laboratory, Insectary, and Experimental Field Station for partner institutions and public-health agencies.

Is CRIDCam a public or private company?

CRIDCam is a private company. It is classified as nonprofit foundation owned and is currently operating.

When was CRIDCam founded?

CRIDCam was founded in 2017. It employs 11 to 50 people.

Where is CRIDCam based?

CRIDCam is headquartered in Yaoundé, Cameroon, in the Africa region.

How does CRIDCam make money?

One revenue line is on record: research Grants and Donor Funding.

Who are CRIDCam's main competitors?

Broad incumbents on record are Swiss Tropical and Public Health Institute (Swiss TPH), Institut de Recherche pour le Développement (IRD), Africa Centres for Disease Control and Prevention (Africa CDC) and London School of Hygiene & Tropical Medicine (LSHTM). Direct peers are Liverpool School of Tropical Medicine (LSTM), Kenya Medical Research Institute (KEMRI), MRC Unit The Gambia at LSHTM, Ifakara Health Institute, Pasteur Institute of Cameroon and Noguchi Memorial Institute for Medical Research (NMIMR).

Does CRIDCam have an API?

No public API is recorded for CRIDCam.

What industry is CRIDCam in?

CRIDCam's product category is Infectious Disease Research Services. Its primary akta.pro industry code is HLAGAAAI, Patient Recruitment, Site Feasibility & Trial Enablement CROs, with a secondary code of HLAGAAAL, Specialty Therapeutic-Area CROs (e.g., oncology/rare disease). Its NAICS code is 5417 and its SIC code is 8731.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals